We are pleased to announce the preliminary program* for BIO Latin America Increase your understanding of, and interaction with, the Latin American biotech market, the varying political landscapes in the region, and their impact on this important industry sector. Topics include: Regional Biotech Development: Frameworks for Innovation Incentivizing Entrepreneurship and Investment in Latin America The […]
If phonetics were the only driver, BRIC would be CRIB. But life sciences drug-related deal-making and partnering growth in Brazil and the rest of Latin America provide good reason to put the “B” in front. Traditional partnerships (i.e. excluding M&A and early venture funding) where a Latin American company served as the ‘seller’ or ‘out-licensor’ doubled per […]
An international confederation of biotech bodies announced the formation of the International Council of Biotechnology Associations (ICBA) today, with the purpose of advocating for public policies that support the growth of the innovative biotechnology industry worldwide. Jim Greenwood, BIO’s President and Chief Executive Officer, was elected ICBA Chairman, and Nathalie Moll, Secretary General of EuropaBio, was elected […]
Brazil steps into the international spotlight as host of the 2014 World Cup and the 2016 Olympics as it celebrates a quarter century of democracy and political stability. The Brazilian economy – now the 7th largest globally by GDP (and averaging $57 billion in FDI inflows annually from 2008 to 2012) – is considered one […]